Trouvez les meilleures technologies du CNRS pour mener à bien votre projet d’innovation.
06.11.2018
Matériaux – Revêtements 07293-01
06.11.2018
Matériaux – Revêtements 10581-01
06.11.2018
Chimie 08758-01
06.11.2018
11127-01
06.11.2018
Environnement et Energie 11107-01
19.10.2018
Diagnostic médical 08504-01
Nous pouvons vous accompagner sur toute votre
démarche de transfert de technologies.
Grâce à notre expérience, nos réseaux et notre connaissance de l’écosystème de l’innovation nous vous accompagnons tout au long de votre projet.
07370-01
Calcium biosensor, bioluminescent sensor, photoprotein, aequorin, redquorin, red-shifted, signal multiplexing, HTS screening, pharmacological assays, drug discovery, toxicity testing, immunoassays, biosensor transgenic lines, screening systems, imaging systems, assays kits
European priority patent application n°15306738.4 filed on October 30, 2015 and entitled “Genetically mutated aequorin-based biosensors with extra sensitivity to calcium and improved bioluminescence intensity” |
Adil BAKAYAN
Nadine PEYRIERAS |
Exclusive or non-exclusive licence |
BioEmergences, USR3695, Gif-sur-Yvette, France
Calcium is known to act as a modulator of many important physiological responses and pathophysiological conditions, participating as a second messenger in the control of a myriad of cellular processes. Among all Ca2+ sensors available, aequorin is a reporter of choice in numerous applications owing to its remarkable flexibility. It is a Ca2+-sensitive photoprotein, a complex of the protein apoaequorin, the coelenterazine (CLZ) and molecular oxygen. However, the light emission from wild type-aequorin, as well as from other photoproteins, is characterized by intrinsically low quantum yield that is proportional to its relatively low sensitivity to calcium. In order to circumvent this issue, incorporation of different CLZ analogs and genetic mutagenesis have been used to alter calcium sensitivity, decay kinetics, spectral emission and thermostability. However, so far no apoaequorin mutant with increased affinity for calcium has been described. Hence, the need for a new generation of apoeaequorin-based calcium biosensors, displaying high affinity to calcium that will significantly enhance the signal-to-noise ratio. Such property is highly desired and would be an essential complementary asset to practically measure minute changes in cellular calcium, which concentration is around several hundreds of nanomolars.
TECHNICAL DESCRIPTION
This invention provides novel apoaequorin-based calcium biosensors (named aequorinXS, 465 nm peak), which have increased affinity for calcium compared to known photoproteins, and exhibit enhanced bioluminescence relative to calcium concentration.
Furthermore, novel red light-emitting aequorinXS versions (RedquorinXS, 581 nm peak) have been enhanced more specifically for multicolor and multiplexing assays, as well as for in vivo imaging.
BENEFITS
AequorinXS and RedquorinXS biosensors have been developed to circumvent the limited calcium sensitivity of the existing photoproteins, hence allowing the following unique properties:
Improved sensitivity to calcium, and therefore increased signal-to-noise-ratio and bioluminescence ouput, while maintaining a low-buffering capacity on cytosolic calcium
Exhibit the necessary characteristics of bioluminescence kinetics and thermostability for detection of changes in intracellular calcium levels, therefore adapted to in vitro, in cellulo and in vivo assays
The red light-emitting variant, RedquorinXS will specifically allow for highly advantageous applications in multicolor modes:
Multiplexed detection of calcium from different cells and/or cellular organelles,
Multiplexed detection of different analytes, calcium and other molecules (e.g. cAMP),
in vivo imaging, giving the low absorbance and scattering of red wavelengths in living tissues (deep tissues and blood cells).
INDUSTRIAL APPLICATIONS
This innovation could be used for:
Quantitative cellular calcium imaging, while allowing multiplexing of blue, green and red emission signals,
High-throughput drug screening based on cell lines expressing GPCRs,
Engineering of stable cell lines for applications in toxicology, genotoxicity and environmental pollution tests,
Engineering of self-illuminating quantum dot conjugates for adapting more colors hues,
Engineering kits with viral particles/AequorinXS/RedquorinXS for delivery into specific or hard-to-transfect cell lines, including ex vivo tissue samples,
Engineering kits with self-penetrating peptide/AequorinXS/RedquorinXS for delivery into hard-to-transfect cell lines, including ex vivo tissue samples,
Immunoassays based on photoprotein bioluminescence, where AequorinXS/RedquorinXS can be modified to target specific functional groups/residues. Aequorin-based labelling is known to reach beyond attomole sensitivity of detection,
Development of bioluminescence imaging systems for dual to three-color (blue, green and red) measurement and screening
DEVELOPMENT STAGE
Accomplished tests:
In vitro characterization of AequorinXS/RedquorinXS (determination of spectral emission, calcium affinity, bioluminescence intensity, bioluminescence kinetics, thermostability)
Assays on live cells (CHO; HEK293T) expressing RedquorinXS using various types of GPCR related agonists/drugs (ATP, Carbachol, Isoproterenol) and other chemical compounds like Forskolin
Engineering of stable cell lines (CHO/RedquorinXS) and characterization in terms of detection limit of ATP molecules, ATP sensitivity and Z-factor determination.
Engineering of viral particles (Sindbis/RedquorinXS), infecting pyramidal neurons from neocortical slices of mice and performing ex vivo imaging of calcium dynamics
Current developments:
Multiplexing synchronous signal detection from mobilization of calcium and cAMP in HEK293T cell line (expressing RedquorinXS and GloSensor cAMP biosensors) after external stimulation
Self-penetrating peptide/RedquorinXS for delivery into blood cells, a hard-to-transfect tissue samples, followed by calcium measurement
In vivo dual-color (green and red) imaging of calcium dynamics in developing zebrafish embryos, by injecting the biosensors in form of DNA, RNA or protein
In vivo imaging of intracranial calcium dynamics in young mice after viral infection of neurons and subsequent expression of RedquorinXS
16.02.2018
Diagnostic médical 86609-04
15.02.2016
Diagnostic médical, Autres technologies 04400-01
05.02.2016
Diagnostic médical 04040-01
06.11.2018
Matériaux – Revêtements 07293-01
06.11.2018
Matériaux – Revêtements 10581-01
06.11.2018
Chimie 08758-01
06.11.2018
11127-01
06.11.2018
Environnement et Energie 11107-01
19.10.2018
Diagnostic médical 08504-01